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Abstract
Background: CD99, a leukocyte surface glycoprotein, is broadly expressed in many cell types. On the cell surface,
CD99 is expressed as two distinct isoforms, a long form and a short form. CD99 has been demonstrated to play a
key role in several biological processes, including the regulation of T cell activation. However, the molecular
mechanisms by which CD99 participates in such processes are unclear. As CD99 contains a short cytoplasmic tail, it
is unlikely that CD99 itself takes part in its multi-functions. Association of CD99 with other membrane proteins has
been suggested to be necessary for exerting its functions.
Results: In this study, we analyzed the association of CD99 with other cell surface molecules involved in T cell
activation. We demonstrate the association of MHC class I, MHC class II and tetraspanin CD81 with CD99 molecules
on the cell surface. Association of CD99 with its partners was observed for both isoforms. In addition, we
determined that CD99 is a lipid raft-associated membrane protein and is recruited into the immunologic synapse
during T cell activation. The implication of CD99 on T cell activation was investigated. Inhibition of anti-CD3
induced T cell proliferation by an anti-CD99 monoclonal antibody was observed.
Conclusions: We provide evidence that CD99 directly interact and form the complex with the MHC class I and II,
and tetraspanin CD81, and is functionally linked to the formation of the immunologic synapse. Upon T cell
activation, CD99 engagement can inhibit T cell proliferation. We speculate that the CD99-MHC-CD81 complex is a
tetraspanin web that plays an important role in T cell activation.
Background
Upon T cell activation, T cell stimulation is initiated
when a T cell receptor (TCR) encounters specific anti-
gen peptide-MHC complexes expressed on the surface
of antigen presenting cells (APCs). The interaction of
various co-stimulatory molecules expressed on T cells
and APCs is, in addition, involved in the induction of
proper T cell responses. These interactions induce the
formation of an immunological synapse (IS) at the cell-
cell junction between T cells and APCs, resulting in the
reorganization of the related cell membrane signaling
molecules in a concerted fashion [1,2]. The IS is
proposed to function as a platform for signal transduc-
tion and cytoskeleton reorganization, which is essential
for the determination of TCR sensitivity and responsive-
ness. Several co-stimulatory molecules have been shown
to translocate into the IS and are crucial in determining
antigen-specific T cell activation and tolerance [2,3].
CD99 has been recently demonstrated to function as a
co-stimulatory molecule in T cell activation [4]. Co-liga-
tion of CD99 and CD3 molecules leads to the transloca-
tion of TCR complexes into the IS and enhances TCR
signaling events.
CD99 is a type 1 transmembrane glycoprotein
encoded by the MIC2 gene, and shares no significant
homology with any known protein family [5-9]. The
CD99 molecule contains an extracellular domain, fol-
lowed by a transmembrane domain and a short 36-
amino acid intracytoplasmic domain [9]. CD99 is
* Correspondence: watchara@chiangmai.ac.th
1Division of Clinical Immunology, Department of Medical Technology,
Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai
50200, Thailand
Full list of author information is available at the end of the article
Pata et al. BMC Research Notes 2011, 4:293
http://www.biomedcentral.com/1756-0500/4/293
© 2011 Kasinrerk et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.broadly distributed among many cell types, both hema-
topoietic and non-hematopoietic cells [10-14]. Although
the functional role of CD99 is not yet fully understood,
it has been implicated in multiple cellular events. CD99
has been described as a T-cell co-stimulator and regula-
tor of cytokine production [4,15]. Engagement of CD99
with agonistic antibodies induced apoptosis of immune
cells and tumor cells [14,16,17]. CD99 ligation was also
demonstrated to induce expression of adhesion mole-
cules, including ELAM-1, VCAM-1 and ICAM-1, which
are associated with leukocyte adhesion and transen-
dothelial migration [13,14,18-24]. Furthermore, CD99
engagement has been reported to induce the expression
of TCR, MHC class I and MHC class II by accelerated
mobilization of these molecules from the Golgi com-
partment to the plasma membrane [25]. Requirement of
CD99 expression in IFN-g induced MHC class I expres-
sion has also been observed [26]. Without CD99, upon
IFN-g stimulation, MHC class I molecules became accu-
mulated within the Golgi apparatus [26].
Signaling pathways triggered by CD99 have been elu-
cidated in several studies. Stimulation of CD99 with
agonistic antibodies enhanced the expression of several
T cell activation markers on anti-CD3-activating T cells,
elevation of intracellular Ca2
+ and the tyrosine phos-
phorylation of cellular proteins [15,27]. We have
demonstrated that protein kinase C inhibitor, sphingo-
sine and a protein tyrosine kinase inhibitor, genistein,
blocked cell aggregation induced by CD99 engagement
[13]. It has also been reported that CD99 ligation
induced differential activation of three mitogen-activated
protein kinase (MAPK) members, ERK, JNK and p38
MAPK [28]. Activation of src kinase and focal adhesion
kinase (FAK) by CD99 molecules has also been demon-
strated [29]. Although several lines of evidence indicate
the involvement of CD99 in cell signaling, with its short
cytoplasmic tail, it is unlikely that CD99 itself takes part
in signaling events. In the cellular context, association of
CD99 with other membrane proteins has been suggested
to be necessary for exerting its functions.
On the cell surface, CD99 is expressed as two distinct
isoforms depending on the alternative splicing of the
encoding gene [22]. The long form (type I) contains 185
amino acid residues and its mobility in SDS-PAGE cor-
responds to an apparent molecular weight (MW) of 32
kDa. The short form (Type II; 161 residues, apparent
MW of 28 kDa) harbors a deletion in the cytoplasmic
segment. The CD99 isoforms are differentially expressed
in a cell type-specific manner among hematopoietic cells
and cell lines [16,22]. The CD99 isoform expression was
shown to dictate distinct functional events [27,30,31].
Expression of the long form in CD99-deficient Jurkat T
cell line is sufficient to promote CD99-induced cell
adhesion, whereas co-expression of the two isoforms is
required to trigger T cell death [16]. In addition, on B
cells, the short form of CD99 inhibited homotypic adhe-
sion, while the activation of the CD99 long form pro-
moted cell-cell adhesion. The opposing effects of CD99
isoforms on homotypic B cell aggregation were shown
to be due to their opposing functions in controlling the
expression of the cell adhesion molecule, LFA-1 [22].
Although the CD99 molecule has been described as a
multi-functional cell surface molecule, it contains a
short intracellular domain [9]. Interaction with other
cell surface molecules is, therefore, assumed to be
necessary in order to regulate its multiple functions. In
this study, we explored the possibility that CD99 may
form a microdomain with other proteins on the cell sur-
face. We demonstrate here the association of MHC class
I, MHC class II and a tetraspanin CD81, with both
CD99 isoforms. Upon T cell activation, translocation of
CD99 into IS and inhibition of T cell proliferation by
anti-CD99 monoclonal antibody (mAb) were observed,
indicating an important role for CD99 in T cell
activation.
Results
Association of CD99 with various membrane proteins
To investigate whether CD99 was associated with other
proteins on the cell surface, co-immunoprecipitations of
biotinylated Jurkat cell lysates using anti-CD99 mAb
MT99/3 [13] were performed. As shown in Figure 1A,
using 1% nonionic detergent Brij-58, a number of mem-
brane proteins with molecular weights of 110, 50 and 40
kDa were co-precipitated with the CD99 molecules. To
exclude the possibility that the observed co-precipitation
Figure 1 Co-immunoprecipitation of CD99 with other
membrane proteins. Immunoprecipitation of biotinylated Jurkat
cell lysates using mild detergent 1% Brij-58 (A) or raft-disrupting
detergent 1% Lauryl maltoside (B). Cell lysates were precipitated
using isotype matched control 4G2 mAb (lane 1) and anti-CD99
mAb MT99/3 (lane 2). Electrophoresis was performed under
reducing conditions. The positions of molecular mass markers are
indicated on the left in kDa. The positions of CD99 molecules are
indicated.
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of lipid raft association, co-immunoprecipitation using
the lipid raft disrupting detergent 1% LM was carried
out. Similar results were obtained (Figure 1B) indicating
that, at the cell surface, CD99 is associated with other
membrane molecules.
Association of CD99 with MHC class I and MHC class II
As CD99 has been reported to transport MHC class I
and class II to the cell surface [25,32], we speculated
that CD99 molecules may be associated with the trans-
ported molecules. To verify this hypothesis, immunopre-
cipitation using anti-CD99 mAb was carried out. The
immunoprecipitated proteins were then analyzed by
Western immunoblotting using the anti-MHC class I
and class II mAbs. However, to obtain more precise
results, we first established CD99 expressing and CD99
non-expressing cells. In order to obtain the appropriate
cell type for preparing CD99 expressing and non-expres-
sing cells, several cell lines were stained with anti-CD99
mAb and analyzed by flow cytometry. It was found that
all of the tested cell lines, including Ramos, Raji, Jurkat,
Molt4, U937 and THP-1, were positive with anti-CD99
mAb (data not shown). However, among the tested cell
lines, only Ramos (a human Burkitt’s lymphoma cell
line) expressed CD99 in a heterogeneous manner, i.e.,
there were CD99 expressing and non-expressing popula-
tions (Figure 2A). The heterogeneous Ramos cells were
then selected and separated by immunomagnetic sorting
resulting in CD99 positive and CD99 negative popula-
tions (Figure 2B and 2C). During long-term cultivation,
the CD99 negative cells retained their CD99 negative
phenotype, while the CD99 positive population returned
to the wild type heterogeneous profile (data not shown).
Hence, the Ramos wild type and CD99 negative cells
were employed for further co-immunoprecipitation
experiments.
As shown in Figure 3A, when using wild type Ramos
cells, MHC class I and MHC class II were co-precipi-
tated with the CD99 molecules. The MHC class II, how-
ever, was demonstrated to co-precipitate with CD99 in
lower amount than the MHC class I molecules (Figure
3A). In contrast, no MHC class I or class II were
detected in the immunoprecipitates resulting from
CD99 negative Ramos cells. CD99, as expected, was
detected only in immunoprecipitates of the wild type,
but not of the CD99 negative Ramos cells. These find-
ings indicated that CD99 physically interacted with
MHC class I and class II. Western immunoblotting of
cell lysates prior to immunoprecipitation were also per-
formed. MHC class I and class II were present in similar
amounts in both the wild type and CD99 negative
Ramos cell lysates (Figure 3A), indicating these mole-
cules can be normally expressed even in the absence of
CD99. In the presence of CD99, nevertheless, the MHC
molecules were expressed as CD99-MHC complexes.
We note that, in the Western immunoblotting experi-
ment using anti-CD99 mAb, CD99 could not be
Figure 2 Immunofluorescenence analysis of CD99 expression on Ramos wild type and CD99 sorted cells. Ramos cells were chosen for
establishment of CD99 expressing and non-expressing cells by an immunomagnetic sorting system using anti-CD99 mAb. The sorted cells were
then verified for their surface CD99 expression by immunoflurorescence and flow cytometry. The wild type (A), CD99 positive (B) and CD99
negative (C) cells were stained with anti-CD99 mAbs MT99/3 and PE-conjugated anti-mouse immunoglobulin antibodies. Solid lines represent
the immunofluorescence profiles of the cells stained with anti-CD99 mAb and dashed lines represent background fluorescence of conjugate
control.
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cell lysates (Figure 3A). It is likely that, as the wild type
Ramos cells expressed CD99 in a heterogeneous pattern
in which a small CD99 positive population was present
(Figure 2A), a small amount of CD99 molecules are
contained in the whole cell lysates. For this reason, the
CD99 molecule could not be detected by Western
immunoblotting.
To confirm the observed association of CD99 with
MHC molecules, reciprocal co-immunoprecipitation
experiments were carried out. In accordance with the
above results, CD99 was observed in the immunopreci-
pitates using anti-MHC class II mAb (Figure 3B). How-
ever, CD99 could not be detected in the
immunoprecipitates using anti-MHC class I mAb (data
not shown). This may be because of the low affinity of
the employed anti-MHC class I mAb itself, resulting in
it being inappropriate for immunoprecipitation. Taken
together, our findings suggest that CD99 form com-
plexes with MHC class I and MHC class II molecules.
Association of CD99-MHC complexes with tetraspanin
CD81
Tetraspanins are broadly expressed cell surface proteins
that span the cell membrane four times [33]. All cells of
the immune system express tetraspanins [34], which
provide a scaffold that facilitates the spatial and tem-
poral engagement of their associated proteins [34,35].
The tetraspanins have been implicated in several cellular
functions such as cell growth, differentiation, intercellu-
lar adhesion, motility, and intracellular signaling [33,35].
Associations of tetraspanins with MHC class I and class
II have been previously described [33,35-37]. CD81, a
member of the tetraspanins, is expressed on T and B
lymphocytes and functions as a co-stimulatory molecule.
The associations of CD81 with MHC molecules have
been described [36,37]. Following our finding of an asso-
ciation between the MHC and CD99 molecules, we
investigated whether the CD99-MHC complex also con-
tained tetraspanins, CD81. Immunoprecipitated proteins
of wild type and CD99 negative Ramos cells were ana-
lyzed by Western immunoblotting using mAb against a
tetraspanin, CD81. CD81, as well as MHC class II and
CD99, were detected in the CD99 immunoprecipitates
of the wild type, but not the CD99 negative Ramos cells
(Figure 4A). To exclude any possible artificial effect of
lipid raft association, we verified the presence of a typi-
cal lipid raft containing molecule, NTAL [38], in the
CD99 immunoprecipitates. As expected, NTAL was not
Figure 4 Association of CD99-MHC class II complexes with
CD81. (A) Cell lysates (lysate) or CD99 immunoprecipitated proteins
(CD99 IP) of wild type (WT) or CD99 negative (N) Ramos cells were
analyzed by Western immunoblotting using the indicated mAbs. (B)
Jurkat cell lysates were immunoprecipitated with the anti-CD99
(CD99), anti-CD81 (CD81) or isotype matched control mAb (control)
and analyzed by Western immunoblotting using the indicated
mAbs. The cell lysate (Lysate) prior to immunoprecipitation was also
analyzed by Western immunoblotting using the indicated mAbs.
Figure 3 Interaction between CD99 and MHC class I and MHC
class II. (A) Cell lysates (lysate) or CD99 immunoprecipitated
proteins (CD99 IP) of wild type (WT) or CD99 negative (N) Ramos
cells were analyzed by Western immunoblotting using the indicated
mAbs. (B) Wild type Raji cell lysates were immunoprecipitated using
anti-CD99 (CD99), anti-MHC class II (MHC II) and isotype matched
control mAbs (control) and analyzed by Western immunoblotting
by using anti-CD99 mAb MT99/3.
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indicating that the association observed is not due to
the occurrence of lipid raft association. Correspondingly,
using Jurkat cells, CD81 and CD99 were observed in the
CD99 immunoprecipitates (Figure 4B), but not in that
using an irrelevant control mAb. Concordantly, the reci-
procal co-immunoprecipitation showed that CD99 and
CD81 were detected in the CD81 immunoprecipitates
(Figure 4B). As Jurkat cells express both CD99 long and
short forms, Western immunoblotting obtained by using
anti-CD99 mAb demonstrated 2 bands corresponding to
the 32 kDa long form and the 28 kDa short form. Col-
lectively, our results indicate that tetraspanin CD81 is
associated with the CD99-MHC complexes.
Colocalization of CD99 with MHC class I, MHC class II and
tetraspanin CD81
To further elucidate the association of CD99 with MHC
and CD81 molecules, colocalization of CD99 and MHC
class I, MHC class II or CD81 were visualized by laser
confocal microscopy. Colocalizations of CD99 and MHC
class I, CD99 and MHC class II as well as CD99 and
CD81 were demonstrated in Raji cell line (Figure 5A).
We note that, in the CD99 and CD81 panel (Figure 5A),
a CD99 negative/CD81 positive cell was captured. This
cell expressed only the green fluorescence of CD81 in
all confocal images, indicating no cross-reactivity
between conjugates and the primary antibodies used. It
is important to mention that not all of the CD99 mole-
cules and MHC or CD81 were associated; some mole-
cules were expressed in an un-associated form. The
confocal imaging results, consistent with the co-immu-
noprecipitation experiments, strongly suggest that CD99
is associated with MHC class I, MHC class II and CD81
on the cell surface.
To demonstrate whether the association of CD99
molecules with its interacting partners is also observed
in peripheral blood cells, colocalization of CD99 with
MHC and CD81 molecules on PBMCs’ membrane were
determined by confocal microscopic analysis. As shown
in Figure 5B, colocalization of CD99-MHC class I,
CD99-MHC class II and CD99-CD81 were observed.
Figure 5 Colocalization of CD99 and MHC class I, MHC class II and CD81. Raji cells (A) or PBMCs (B) were stained with anti-MHC class I
(MHC I), anti-MHC class II (MHC II), anti-CD81 (CD81) and anti-CD99 (CD99) mAbs as described in Materials and Methods. In IgG control, PB1
mAb (for Raji) or MEM-111 mAb (for PBMCs) were used instead of anti-MHC or anti-CD81 mAb. The stained cells were analyzed for
colocailization by a confocal microscope. The green images represent the distribution of MHC class I, MHC class II, CD81 molecules and red
images represent the CD99 molecules. Cell nuclei are shown in blue.
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sing CD99 and MHC or CD81. In IgG control, anti-
CD54 mAb was used instead of anti-MHC class I, class
II or CD81 and found no colocalization between the
CD99 and CD54 molecules indicating no cross-reactivity
between conjugates and the primary antibodies used.
These results indicated that association of CD99 with
MHC and CD81 is physically occurred in peripheral
blood cells.
Association of CD99 short and long forms with MHC class
I, MHC class II and CD81
CD99 molecules are expressed on the cell surface in two
isoforms, a 28 kDa short form and 32 kDa long form.
As described above, we have demonstrated that MHC
class I, MHC class II, and CD81 are associated with the
CD99 molecules. To determine whether this association
is dependent on the CD99 isoforms, we have developed
Ramos cells expressing CD99 short and long forms,
using retroviral vectors encoding the respective iso-
forms. The expression of CD99 in the generated stable
cell lines was verified by flow cytometry (Figure 6A) and
immunoprecipitation (Figure 7). Immunoprecipitation of
CD99 molecules followed by Western immunoblotting
with anti-CD99 mAb demonstrated the expected surface
expression patterns on the transduced cells (Figure 7).
We performed immunoprecipitations from the lysates
of cell lines expressing selectively the two CD99 iso-
forms using anti-CD99 mAb and analyzed the immuno-
precipitates by Western immunoblotting. As shown in
Figure 7A and 7B, MHC class I, MHC class II, and
CD81 could be detected in the immunoprecipitates
obtained from cells expressing both the CD99 short and
long forms. No immunoreactive band could be observed
in the control immunoprecipitate of CD99 negative
Ramos cell lysates. As anticipated, the typical lipid raft
containing molecule NTAL was not detected in the
CD99 immunoprecipitated proteins (Figure 7B). Collec-
tively, the results suggest that the association of MHC
class I, MHC class II and CD81 with CD99 can be
observed in both CD99 isoforms.
Recruitment of CD99 into the immunological synapse (IS)
Since our results suggest that MHC class I, class II and
CD81, which are accessory molecules for T cell activa-
tion and are accumulated in the IS, are associated with
CD99, we further investigated whether CD99 also
Figure 6 Flow cytometric analysis of CD99 expression of Ramos expressing CD99 short and long forms. CD99 negative Ramos cells were
transduced with retrovirus carrying CD99 short form (CD99 SF Ramos cells) or CD99 long form (CD99 LF Ramos cells). The transduced cells were
stained with the anti-CD99 mAb MT99/3 and counterstained with PE-conjugated anti-mouse immunoglobulins antibodies. Solid lines represent
the immunofluorescence profiles of the cells stained with anti-CD99 mAb and dashed lines represent background fluorescence of conjugate
control.
Figure 7 Interaction between CD99 isoforms with MHC class I,
class II and CD81. Cell lysates (Lysate) or CD99 immunoprecipitates
(CD99 IP) of Ramos expressing CD99 short form (CD99SF), CD99
long form (CD99LF) and CD99 negative Ramos (CD99neg) were
analyzed by Western immunoblotting using anti-MHC class I, anti-
MHC class II and anti-CD99 mAbs (A) or anti-CD81, anti-CD99 and
anti-NTAL mAbs (B). The positions of CD99 short and long isoforms
are indicated.
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loaded Raji B cells with SEB and incubated them with
DDAO-SE pre-labeled Jurkat T cells. As shown in Fig-
ure 8A, CD99 accumulated at the T-B cell interface.
Colocalization of CD99 with F-actin, a marker of IS for-
mation, was also observed. These data suggest that
CD99 is recruited to the IS.
Immune cell signaling pathways are at least partially
mediated by lipid raft-associated proteins. During T cell
activation, lipid rafts are accumulated in the IS and
function as the platform for signal molecules [39]. We
thus attempted to confirm whether, in the Jurkat T cell
line, CD99 is a lipid raft-associated membrane protein.
As shown in Figure 8B, in the presence of mild lipid
raft-preserving detergent 1% Brij-98, both short and
long forms of CD99 were found in the raft and non-raft
fractions. In contrast, in the presence of the raft disrupt-
ing detergent 1% LM, CD99 was mostly found in the
non-raft fractions. The lipid raft containing protein Lck
was included in the experiment as a positive control and
was observed in the lipid raft fractions. These results
indicate that CD99 molecules are recruited to the IS
and a fraction of CD99 is associated with lipid rafts.
Inhibition of T cell proliferation by engagement of
surface CD99
To determine whether CD99 is involved in T cell activa-
tion, peripheral blood mononuclear cells (PBMCs) were
activated with anti-CD3 mAb OKT3 in the presence of
anti-CD99 mAb MT99/3 and cell proliferation was veri-
fied. As shown in Figure 9, engagement of CD99 inhib-
ited T cell proliferation. In contrast, the isotype
Figure 8 CD99 is recruited into the IS and lipid rafts. (A) DDAO-SE pre-labeled Jurkat T cells were incubated with SEB-loaded Raji B cells.
Cells were then plated onto a cover slip, fixed, stained with anti-CD99 mAb followed by Alexa Fluor 488-conjugated goat anti-mouse IgG
antibodies, TRITC-phalloidin for F-actin and Hoechst 33258 for the nucleus. The stained cells were visualized by confocal fluorescence
microscopy. The green and yellow images represent the localization and distribution of CD99 and F-actin, respectively. The nuclei and Jurkat
cells are shown in blue and red, respectively. (B) Jurkat cells were homogenized to isolate cell membranes, which were then solubilized in lipid
raft preserving detergent 1% Brij-98 or lipid raft disrupting detergent 1% Lauryl maltoside (LM) and subjected to gel filtration on Sepharose 4B.
The obtained fractions were analyzed by Western immunoblotting using anti-CD99 and anti-Lck mAbs.
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effect. These results indicate that CD99 play a regulatory
role in T cell activation.
Discussion
Cell surface molecules containing a short cytoplasmic
tail usually form complexes with other molecules in
order to modulate their signal transduction and func-
tions. Identification of the interacting partners of cell
surface molecules may lead to a better understanding of
cellular function and immune responses. In the present
study, we have identified several interacting partners of
a multi-functional membrane protein, CD99. We
observed that on the cell surface, CD99 molecules are
associated with MHC class I, MHC class II and tetraspa-
nin CD81. The CD99 molecule has been described by
several studies as a signaling molecule. Engagement of
CD99 induces signal transduction, resulting in the regu-
lation of T cell activation, cell adhesion, cell migration,
and cell death. However, CD99 itself contains a short
intracellular domain without signaling motifs on the
cytoplasmic tail except a site for PKCa phosphorylation
[9,30]. Signal transduction induced by CD99 is, there-
fore, incompletely understood. Since we found, in this
study, that CD99 form complexes with other signal
mediated molecules, i.e., MHC class I, MHC class II and
tetraspanin CD81, this may help to clarify the precise
signaling mechanism of the CD99 molecule and provide
better understanding of its functional roles.
MHC molecules are cell surface proteins that play a
critical role in antigen presentation. CD99 has been
reported to regulate the expression of MHC class I and
class II [25,26,32]. Up-regulation of MHC class I and
class II by CD99 results from accelerated intracytoplas-
mic transportation of MHC molecules to the plasma
membrane rather than de novo synthesis of these mole-
cules [25,32]. Deceased expression of CD99 resulted in
the retention of MHC class I molecules in the Golgi
compartment by affecting the transportation of the
MHC molecules in the trans-Golgi network [26,32].
Moreover, colocalization of CD99 and MHC class I
molecules is clearly demonstrated both in the Golgi
apparatus and at the cell surface [26]. Strikingly, it was
demonstrated that the CD99 and MHC class I associa-
tion occurs at the transmenbrane domain. Valines
located in the transmembrane region of CD99 are
required for the binding to MHC molecules, likely in
relation with their hydrophobicity [26]. In agreement
with the previous reports, in this study, we have shown
that, after transportation, the CD99 molecules form
complexes with their transported MHC molecules and
are co-expressed as microdomains on the cell surface.
In addition to the MHC molecules, we demonstrated
the association of CD99 with a tetraspanin, CD81. The
Figure 9 Engagement of CD99 inhibits T cell proliferation. PBMCs were labeled with CFSE and cultured with or without anti-CD3 mAb OKT3
in the absence or presence of anti-CD99 mAb MT99/3 or isotype matched control mAb 13 M for 5 days. Cells were then harvested and acquired
in a flow cytometer. (A) FACS profiles illustrate the T-cell proliferation levels obtained in the different indicated conditions, as determined by
CFSE fluorescence loss. (B) Histogram plots show the level of cell proliferation as determined by the percentage of dividing cells in the indicated
culture conditions.
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expressed in many cell types. Data from biochemical
studies or knockout mice suggest that the tetraspanins
play a major role in membrane biology [33,35]. One of
the most striking features of tetraspanins is their ability
to form a network of multi-molecular complexes,
known as the tetraspanin web, between each individual
tetraspanin and other surface proteins. Within the
immune cells, all cells express tetraspanins, which pro-
vide a scaffold that facilitates the spatial and temporal
engagement of their associated proteins. Tetraspanins
and their associated proteins modulate several intercel-
lular immune interactions, including adhesion, migra-
tion, synapse formation, as well as assisting in
intracellular interactions as organizers of membrane-sig-
naling complexes. They are also involved in intracellular
protein transport, endocytosis, and exocytosis, and func-
tion as chaperones or stabilizers of lineage-specific
molecules. CD81, a member of the tetraspanins, has
been reported to be involved in an astonishing range of
physiological responses [33,35,40]. Association of CD81
with various surface molecules, including MHC class II,
has previously been reported. As our results demon-
strated the association of CD99 with CD81 and MHC
molecules, we speculate that the CD99-MHC-CD81
complex is a tetraspanin web and plays an important
role in the immune response.
CD99 is expressed as two distinct isoforms, a long 32
kDa form (type I) and a short 28 kDa form (type II)
resulting from an alternative splicing process of the pro-
duct of the encoding gene [22]. In the immune cells,
CD99 are expressed in both short and long forms
[16,22]. Both isoforms have their functional roles, and
differential expression can lead to distinct functional
outcomes [27,30,31]. The truncation of the cytoplasmic
domain of the CD99 short form may result in a loss of
interaction with signaling molecules recognized by the
cytoplasmic domain of the long form. It has been
demonstrated that the cytoplasmic domain of the long
form contains two putative phosphorylation sites, a ser-
ine at amino acid residue 168 and a threonine at amino
acid residue 181. These potential phosphorylation sites
may be important for intracellular signaling events and/
or extracellular molecular interactions. Moreover, the
S168 of CD99 long form has been reported to be a site
for PKCa phosphorylation and is required for the onco-
suppressor function [41]. It has also been postulated
that truncation of the cytoplasmic domain of the CD99
short form causes an alteration of the three-dimensional
structure, leading to different binding sites for its ligand.
However, it is still unknown whether CD99 mediated
signaling pathways are modulated by the differential
expression of CD99 isoforms [16,22] or whether each
CD99 isoform promotes different sets of signaling
pathways [31]. To address the mechanisms of differing
functions of the two CD99 isoforms, we investigated
whether the association of CD99 with its partner mole-
cules depended on the distinct isoform. We, however,
found that both CD99 isoforms interacted with MHC
and CD81 molecules. It is tempting to assume that the
association of CD99 with MHC and tetraspanin CD81
may bring both CD99 isoforms into the tetraspanin web
and into close proximity with the intracellular mem-
brane signaling proteins. The molecular mechanism by
which CD99 mediated signaling occurs is likely to
reflect the presence of signaling molecules, such as
kinases [42,43] and phosphatases [44], in the tetraspanin
microdomain. This is, however, only speculation and
requires further investigation.
The IS is a dynamic structure formed between T cells
and antigen presenting cells, and is characterized by
lipid and protein segregation, signaling compartmentali-
zation, and bidirectional information exchange through
soluble and membrane-bound transmitters [45]. The IS
is the site where signals are delivered by the T cell
receptors, adhesion molecules, as well as co-stimulatory
and co-inhibitory receptors. The IS is divided into dis-
tinct regions: a central-supramolecular activation cluster
(c-SMAC), a peripheral-(p-) SMAC, and a distal-(d-)
SMAC [45]. It has been demonstrated that the c-SMAC
mediates antigen recognition and subsequent T cell acti-
vation, whereas the p-SMAC supports T cell-APC con-
jugation and maintains the architecture of the IS.
Several molecules, including MHC and tetraspanin
CD81, have been shown to translocate into the IS dur-
ing T cell activation [33,35,46]. Upon T cell activation,
CD81 is redistributed to the contact area of T cell-APC
conjugates of both T cells and APCs. Colocalization of
CD81 with CD3 at the SMAC of T cells and of CD81
with MHC class II of APCs has been observed in which
they function as cell surface co-stimulatory molecules.
As CD99 form complexes with MHC and CD81 mole-
cules, we investigated whether CD99 is translocated into
the IS upon TCR triggering. We demonstrated that
CD99 is a lipid raft-associated protein and is recruited
into the IS, as has been observed for its associated mole-
cules. Engagement of CD99 with agonistic antibody
inhibits T cell activation. To our knowledge, this is the
first demonstration of the accumulation of CD99 within
the IS upon T cell activation and the association of
CD99 with the proteins of the SMAC. We speculate
that CD99-MHC-tetraspanin CD81 complexes may play
an important role in T cell activation.
Conclusions
In the present study, we demonstrate that CD99 is asso-
ciated with MHC class I, MHC class II and a tetraspa-
nin, CD81. The association was observed in both CD99
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Page 9 of 13long and short isoforms. Our data collectively show that
upon T cell activation, CD99 is translocated into the IS
and involved in regulation of T cell proliferation. The
CD99-MHC-CD81 complexes may play an important
role in immune responses.
Methods
Antibodies, reagents and cell lines
A n t i - C D 9 9m A b sc l o n e sM T 9 9 / 3( I g G 2 a )a n dM T 9 9 / 1
(IgM) were produced in our laboratory [13,14]. Anti-
CD54 mAb MEM-111 (IgG2a), anti-MHC class I mAb
HC10 (IgG1), anti-MHC class II mAb MEM-136 (IgG1),
anti-CD81 mAb M38 (IgG1), anti-NTAL mAb NAP-07
(IgG1), anti-Lck mAb Lck-01 (IgG1) and anti-CD45
mAb MEM-55 (IgG1) were kindly provided by Prof.
Vaclav Horejsi (Institute of Molecular Genetics, Acad-
emy of Sciences of the Czech Republic, Prague, Czech
Republic). Isotype matched control mAbs, PB-1 (anti-
hemoglobin Bart’s; IgG1) and 13 M (anti-bacteriophage
protein; IgG2a) were generated in our laboratory. Iso-
type matched control mAbs 4G2 (anti-dengue viral pro-
tein; IgG2a) and were obtained from Dr. Prida Malasit
(Division of Medical Molecular Biology, Faculty of Med-
icine Siriraj Hospital, Mahidol University, Bangkok,
Thailand). Fluorescein isothiocyanate (FITC)- and Phy-
coerythrin (PE)-conjugated sheep F(ab’)2 anti-mouse
immunoglobulin antibodies were purchased from Che-
micon Australia Pty Ltd (Victoria, Australia) and Beck-
man Coulter (Marseille, France), respectively. Alexa
Fluor 488-labeled goat anti-mouse IgG antibodies, Alexa
Fluor 568-labeled goat anti-mouse IgM antibodies, Cell-
Trace™ Far Red DDAO-SE and Hoechst 33258 dye
were obtained from Invitrogen (Carlsbad, CA, USA).
Horseradish peroxidase (HRP)-conjugated rabbit anti-
mouse immunoglobulin antibodies and HRP-conjugated
streptavidin were obtained from Dako (Glostrup,
Denmark).
Sulfo-NHS-LC-Biotin and detergent Brij-58 were
obtained from Pierce (Rockford, IL, USA). Laurylmalto-
side (n-dodecyl-b-D-maltoside; LM) was obtained from
Calbiochem/Merck (Darmstadt, Germany). Detergent
Brij-98, protease inhibitors (phenylmethylsulfonyl fluor-
ide (PMSF), pepstatin A, aprotinin), TRITC-phalloidin
and Staphylococcal enterotoxin B (SEB) were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
Several cell lines including Ramos (human Burkitt’s
lymphoma cell line), Raji (human Burkitt’s lymphoma
cell line), Jurkat (human T cell lymphoblast-like cell
line), Molt4 (human acute lymphoblastic leukemia cell
line), U937 (human leukemic monocyte lymphoma cell
line) and THP-1 (human acute monocytic leukemia cell
line) were used in this study. All cell lines were main-
tained in RPMI-1640 medium supplemented with 10%
fetal calf serum (FCS) (Gibco, Grand Island, NY), 40 μg/
ml gentamycin and 2.5 μg/ml amphotericin B in a
humidified atmosphere of 5%CO2 incubator at 37°C.
Co-immunoprecipitation of cell surface molecules
Jurkat cells were labeled with 5 mM Sulfo-NHS-LC-Bio-
tin at 4°C for 1 hr. The biotinylation was quenched by
washing once with 1 mM glycine in PBS and twice with
PBS. The biotinylated cells (5 × 10
7 cells) were solubi-
lized for 30 min on ice in 1 ml lysis buffer (20 mM
Tris-HCl pH 7.5, 100 mM NaCl, 2 mM EDTA, 50 mM
NaF, 1 mM Na3VO4, 5 mM iodoacetamide, and pro-
tease inhibitors) containing either detergent 1% Brij-58
or 1% LM. The cell suspension was clarified by centrifu-
gation at 10,000 × g for 30 min at 4°C. The clarified cell
lysates were precleared with protein G Sepharose beads
(Pierce) coated with mouse immunoglobulins. The pre-
cleared lysates were then incubated with 10 μgo fp u r i -
fied mAbs for 2 hr at 4°C. Protein G Sepharose beads
were added and the mixtures were rotated overnight at
4°C. After incubation, beads were washed five times,
and proteins were dissociated from the Protein G beads
by addition of SDS-reducing sample buffer (62.5 mM
Tris-HCl pH 6.8, 5% b-mercaptoethanol, 2% sodium
dodecyl sulfate (SDS), 10% glycerol, and 0.01% bromo-
phenol blue) and boiled for 5 min. The precipitated
proteins were then resolved by SDS-polyacrylamide gel
electrophoresis (PAGE) and subsequently transferred to
a nitrocellulose membrane (Pall Corp., East Hill, NY,
USA). The membrane was blocked overnight in PBS
containing 5% BSA at 4°C. The blocked membrane was
incubated for 1 hr at room temperature with HRP-con-
jugated streptavidin. The reactive protein bands were
visualized by the chemiluminescence detection system
(Pierce).
Co-immunoprecipitation of un-labeled cell lysates and
Western immunoblotting
The tested cell lines (5 × 10
7 cells) were pelleted and
lysed with 1 ml lysis buffers containing either 1% Brij-58
or 1% LM for 30 min on ice. The lysates were clarified
by centrifugation. The immunoprecipitations were per-
formed according to the method described above. The
precipitated proteins were resolved by SDS-PAGE under
non-reducing conditions and transferred to a nitrocellu-
lose membrane, followed by Western immunoblotting
experiments. The nitrocellulose membranes were
blocked with 5% BSA in PBS at room temperature for 1
hr. Then, the blocked membrane was incubated with
mAbs for 1 hr at room temperature. After being washed
five times with 0.1% Tween-20 in PBS, the membrane
was incubated with HRP conjugated rabbit anti-mouse
immunoglobulin antibodies for 1 hr. The specific pro-
tein bands were then visualized by the chemilumines-
cence detection system (Pierce).
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Ramos cells by immunomagnetic cell sorting
Ramos cells were stained with anti-CD99 mAb MT99/3
for 30 min on ice. Then, FITC-conjugated anti-mouse
immunoglobulin antibodies were added and incubated
for 30 min on ice. After incubation, cells were washed
and incubated with anti-FITC MicroBeads (Miltenyi
Biotec, Bergisch Gladbach, Germany) according to the
manufacturer’s instructions. Cells were washed and
resuspended in MACS sorting buffer (0.5% BSA, 2 mM
EDTA in PBS) and sorted with an AutoMACS cell sor-
ter (Miltenyi Biotec). The obtained positive and negative
cell fractions were collected and cultured in RPMI-1640
medium supplemented with1 0 %f e t a lb o v i n es e r u m
(FBS) (Gibco, Grand Island, NY, USA), 40 mg/ml genta-
micin and 2.5 mg/ml amphotericin B in a humidified
atmosphere of 5% CO2 at 37°C. CD99 expression on the
sorted cells was verified by flow cytometric analysis.
Co-localization analysis
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from heparinized whole blood of healthy donors
by Ficoll-Hypague density gradient centrifugation.
PBMCs or Raji B cell line (1 × 10
7 cells/ml) was pre-
incubated with 10% human serum (blood group AB) at
4°C for 30 min. For staining of the surface membrane
proteins, 50 μl of the cell suspension were incubated
with an equal volume of 20 μg/ml anti-MHC class I,
anti-MHC class II, anti-CD81 mAbs, or isotype matched
control PB-1 mAb (for Raji) or MEM-111 mAb (for
PBMCs) at 4°C for 30 min. The cells were washed twice
with PBS containing 1%BSA and 0.02% NaN3 (1% BSA-
PBS-NaN3) and then incubated with Alexa Fluor 488-
conjugated goat F(ab’)2 anti-mouse IgG antibodies at 4°
C for 30 min. After twice washing, the cells were then
incubated with mouse immunoglobulins at 4°C for 30
min to neutralize the reactivity of the adding conjugates.
Subsequently, CD99 molecules were stained using anti-
CD99 mAb MT99/1 (IgM isotype) at 4°C for 30 min,
followed by Alexa Fluor 568-conjugated goat F(ab’)2
anti-mouse IgM antibodies at 4°C for 30 min. Finally,
cells were fixed with 4% paraformaldehyde for 15 min at
room temperature and plated on poly-D-lysine coated
slides. Cell nuclei were visualized with Hoechst 33258
dye. For evaluation of colocalization, cells were visua-
lized and images were acquired using a confocal laser
scanning microscope (LSM 700; Zeiss, Le Pecq, France).
Generation of Romos cell expressing CD99 short and long
isoforms
Plasmid DNA encoding full-length CD99 cDNA [13]
w a su s e da sat e m p l a t ef o rg e n e r a t i o no fc D N Ae n c o d -
ing CD99 short and long forms by the polymerase chain
reaction (PCR). The PCR products were inserted into
the EcoRI site of the MSCV retroviral vectors, according
to the manufacturer’s instructions (Clonetech Labora-
tory, Mountain View, CA, USA). The obtained plasmid
DNA were transformed into E. coli TOP10 (Invitrogen).
The plasmid DNA were then isolated from the trans-
formed E. coli by Qiagen chromatography columns
(Qiagen, Hilden, Germany). The inserted genes in the
constructed plasmids were checked by restriction frag-
ment analysis using corresponding restriction enzymes
and DNA sequencing.
To prepare retroviruses (RV) harboring plasmid carry-
ing CD99 isoforms, the plasmid DNA were transfected
into Phoenix-Ampho cells (Origene, Rockville, MD,
USA) using Lipofectamine (Invitrogen). At 48 hr post-
transfection, RV-containing supernatants were collected
and clarified by centrifugation. The RV were then used
to spin-infect (1200 × g, 90 min at 32°C) the Ramos
CD99 negative cells in the presence of polybrene (10
μg/ml)(Sigma-Aldrich). Cells were allowed to expand in
culture and sorted by immunomagnetic cell sorting to
isolate the CD99 expressing cells. Stable transfectant
clones with high CD99 expression were identified by
flow cytometric analysis.
Flow cytometric analysis
Cells (1 × 10
7cells/ml) were pre-incubated with 10%
human serum (blood group AB) at 4°C for 30 min to
block nonspecific Fc-receptor-mediated binding of
mAbs. For staining of the surface membrane proteins,
50 μl of the cell suspension were incubated with an
equal volume of 20 μg / m la n t i - C D 9 9m A bM T 9 9 / 3a t
4°C for 30 min. The cells were washed twice with 1%
BSA-PBS-NaN3 and then incubated with PE-conjugated
sheep F(ab’)2 anti-mouse immunoglobulin antibodies at
4°C for 30 min. Cells were washed and membrane fluor-
escence was analyzed by a flow cytometer (FACSCalibur;
Becton Dickinson, Sunnyvale, CA, USA).
Immunological synapse and confocal image analysis
Raji B cells (1 × 10
7 cells/ml) were loaded with 1 μg/ml
of staphylococcal enterotoxin B (SEB) (Sigma-Aldrich)
for 15 min at 37°C. Jurkat T cells (1 × 10
7 cells/ml)
were labeled with CellTrace™ Far Red DDAO-SE. After
washing, an equal number of Jurkat cells were mixed
with Raji cells and incubated at 37°C for 15 min. Cell
mixtures were placed on poly-D-lysine coated slides,
fixed with 4% paraformaldehyde for 15 min at room
temperature and permeabilized with 0.1% Triton X-100
for 5 min on ice. Cells were then incubated with anti-
CD99 mAb MT99/3 for 30 min at room temperature.
Alexa Fluor 488-labeled goat anti-mouse IgG secondary
antibody and TRITC-phalloidin were added and incu-
bated for 30 min. Cell nuclei were stained with Hoechst
33258 dye. The stained cells were analyzed and images
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scope (LSM 700; Zeiss, Le Pecq, France).
Determination of CD99 in lipid rafts
Lipid rafts were isolated according to the method
described elsewhere [47]. Briefly, cells (1 × 10
8)w e r e
resuspended in 0.4 ml of ice-cold hypotonic buffer (10
mM HEPES pH 7.4, 42 mM KCl, 5 mM MgCl2,a n d
protease inhibitors), incubated on ice for 15 min and
then passed 10 times through the 30-gauge needle. The
suspension was centrifuged for 5 min, 300 × g, at 2°C to
remove nuclei. The supernatant was re-centrifuged for
10 min, 25,000 × g, at 2°C to sediment the membranes.
Membranes were then lysed in 0.2 ml of lysis buffer
containing 1% Brij-98 or 1% LM for 30 min on ice, and
spun at 10,000 × g for 30 min. The clarified lysates (0.1
ml) were applied at the top of a 1 ml Sepharose 4B col-
umn (Sigma-Aldrich) and sequentially washed with 0.1
ml of the lysis buffer. The fractions (0.1 ml) were col-
lected at 4°C and analyzed for the presence of CD99 by
SDS-PAGE and Western immunoblotting.
Proliferation assay
PBMCs were isolated from heparinized whole blood of
healthy donors by Ficoll-Hypague density gradient cen-
trifugation. Cells (1 × 10
7 cells/ml in PBS) were incu-
bated with 0.5 μM carboxyfluorescein diacetate
succinimidyl ester (CFSE; Molecular Probes, Eugene,
O R ,U S A )a t3 7 ° Cf o r1 0m i n .T h eC F S Es t a i n i n gw a s
terminated by adding cold RPMI-1640 medium supple-
mented with 10% fetal bovine serum (FBS; Gibco,
Grand Island, NY, USA), 40 mg/ml gentamicin, and 2.5
mg/ml amphotericin B (10% FBS-RPMI 1640). The cells
were then washed twice and resuspended with 10% FBS-
RPMI 1640. To determine the influence of anti-CD99
mAb on T cell activation, CFSE labelled PBMCs (5 ×
10
5 cells) were cultured in 96-well plate with or without
immobilized anti-CD3 mAb OKT3 (60 ng/ml) in the
presence or absence of 20 μg/ml anti-CD99 mAb or iso-
type matched control mAb. The plate was cultured at
37°C in a 5% CO2 incubator for 5 days. Cells were then
harvested and determined for cell proliferation by flow
cytometry (Becton Dickinson).
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